Esmolol hydrochloride

Esmolol hydrochloride is an extremely brief appearing selectivity of aryloxypropylamine β 1 receptor blocker, ordinarily inhibited with the aid of competing for catecholamine binding web sites β 1 receptor, which has consequences such as slowing down resting and workout coronary heart rate, decreasing blood pressure, and myocardial oxygen consumption. At the identical time, it has the traits of quickly onset, excessive bioavailability, brief half-life, particular therapeutic effect, and low facet effects. Currently, it is generally used in scientific exercise for the remedy of supraventricular arrhythmias and acute myocardial ischemia, and has giant therapeutic results on acute myocardial infarction, unstable angina, postoperative hypertension, and different diseases.